Yahoo Web Search

Search results

  1. Jul 17, 2020 · “We show that BCG is similar to checkpoint inhibitors in that it works by eliciting an immune response against cancer neoantigens,” says Gil Redelman-Sidi, a physician-scientist who collaborates with Dr. Glickman and is the co-corresponding author on the PNAS paper. “These results bring BCG into the modern world of immunology.”

  2. Jun 15, 2021 · This work was funded by the National Institutes of Health (grants R01AI138446, U19AI11143, and P30 CA008748). Dr. Glickman is a consultant for Fimbrion Therapeutics, serves on the SAB of Vedanta Biosciences and receives consulting fees and equity, and serve­­s on the SAB of PRL NYC.

  3. Cleveland Clinic’s Glickman Urological and Kidney Institute, recognized worldwide for excellence in patient care, teaching and research, merges the urology and kidney medicine programs. This consolidation of disciplines allows us to better serve patients in the prevention, diagnosis and treatment of kidney disease while we continue to provide ...

    • Education
    • Honors / Credentials
    • Current Funding

    Certificate, Oral and Maxillofacial Surgery, NYU/Bellevue Hospital Center 1982 DMD, University of Pittsburgh School of Dental Medicine 1978

    Board Certification in Oral & Maxillofacial Surgery by the American Board of Oral and Maxillofacial Surgery, 1982

    Dean's Faculty Research Award: Allele Frequencies and the Loss of Heterozygosity at the SeP15 Locus in Head and Neck Tumors from African Americans.
    New York University Medical Center: Patterns of Craniofacial Growth Following Pediatric Skull Base Irradiation
    Biomedical Research Alliance of New York, LLC: Protocol AAI-000395: A Phase III Randomized, Multicenter, Parallel group, Double masked, Placebo-controlled Study of the Safety and Efficacy of a Sing...
    Bellevue Hospital Center: Use of Aredia to Treat Patients with Craniofacial Fibrous Dysplasia and Giant Cell Lesions.
  4. 222 E 41st Street (Langone Medical Center) Dr. Robert S. Glickman. Dr. Robert S. Glickman is Chair of the Mecca Department of Oral and Maxillofacial Surgery at NYU College of Dentistry. He is a Diplomate of the American Board of Oral and Maxillofacial Surgery, and a member of the New York Academy of Medicine. Dr.

    • Who is Dr. Glickman?1
    • Who is Dr. Glickman?2
    • Who is Dr. Glickman?3
    • Who is Dr. Glickman?4
    • Who is Dr. Glickman?5
  5. Head of Epidemiology, Climate and Global Health - Health Analysis and Life Events at Office for National Statistics · 35 years professional experience in health statistics and informatics;<br>20 years senior management experience in the UK government;<br>15 years teaching and examining in health information subjects;<br>Innovations in health data collection and analytical ...

    • Office for National Statistics
  6. People also ask

  7. May 8, 2018 · Dr. Glickman is the founder, CEO and chairman of Aurinia Pharmaceuticals. He was a co-founder, chairman and CEO of Aspreva Pharmaceuticals, playing an integral role in the development and establishment of CellCept®, or MMF, as the current standard of care for lupus nephritis. Aspreva Pharmaceuticals was acquired by Swiss pharmaceutical company ...

  1. People also search for